跳至主要内容
临床试验/NCT01811199
NCT01811199Unknown不适用

Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2α and LTC4 Levels

Marmara University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2011年2月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Number of participants will be evaluated to show effect of dexamethasone in reducing postoperative emesis

研究概览

简要总结

Hypothesis: Dexamethasone reduces postoperative emesis in thyroidectomy and mastectomy patients.

详细描述

This study has been done to further study the effectiveness of dexamethasone in the prevention of postoperative emesis after breast and thyroid surgery and at the same time, the mechanism of action was investigated. In this prospective, randomized controlled trial it was hypothesized that corticosteroids exert their antiemetic effects in postoperative period via plasma prostaglandin F2 alpha (PGF2 α) and plasma leukotriene C4 (LTC4) inhibition.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • breast and thyroid cancer patients no neoadjuvant treated no NSAID or steroid usage heallthy volunteers, signed the informed consent

排除标准

  • ones who did not sign the consent form NSAID or steroid users

结局指标

主要结局

Number of participants will be evaluated to show effect of dexamethasone in reducing postoperative emesis

时间窗: up to 3 days

participants will be followed for the duration of hospital stay, till they are discharged in avarage 3 days for postoperative emesis.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

A.Ozdemir Aktan

professor of surgery

Marmara University

研究点 (1)

Loading locations...

相似试验